
    
      To measure changes in Health Related Quality of Life (as measured by the Insulin Therapy
      Related-Quality of Life: ITR-QOL) in insulin treated type 2 diabetes over a 12 weeks period
      following a significant change in insulin treatment regimen. Definition of significant change
      is a) increase or decrease the in number of injections per day, or/and b) change in
      formulation of insulin (human or analog insulin, basal or bolus, rapid or mix insulin),
      and/or c) change in administration method (syringe or pen, disposal or re-usable).
    
  